The global vitamin K2 market size was valued at USD 307.66 million in 2025 and is projected to grow from USD 347.44 million in 2026 to USD 919.07 million by 2034 at a CAGR of 12.93% during the forecast period 2026-2034. North America dominated the vitamin K2 market with a market share of 37.2% in 2025.
Vitamin K2 is a fat-soluble vitamin that plays a crucial role in calcium metabolism, supporting bone mineralization and cardiovascular health. It activates proteins that help direct calcium to bones and teeth while preventing its accumulation in arteries. K2 is commonly used in dietary supplements, functional foods, and fortified beverages. Its applications span preventive healthcare, sports nutrition, and elderly care, helping maintain skeletal strength, improve arterial flexibility, and enhance overall wellness.
Download a Free Sample To learn more about this report,
The global vitamin K2 market is witnessing strong momentum as consumer awareness around bone health continues to rise. With increasing cases of osteoporosis and fractures among aging populations, more individuals are turning to supplements fortified with vitamin K2. This trend is further supported by doctors recommending preventive nutrition solutions.
Beyond bone health, consumers are also recognizing the role of vitamin K2 in cardiovascular wellbeing, particularly its ability to regulate calcium deposition in arteries. As research findings become widely accessible through digital platforms and healthcare campaigns, awareness is translating into growing demand for vitamin K2 supplements and fortified food products.
Rising Prevalence of Osteoporosis and Cardiovascular Diseases
The increasing burden of osteoporosis and cardiovascular diseases is significantly boosting vitamin K2 market demand. Aging populations, sedentary lifestyles, nutritional deficiencies, and changing dietary habits are increasing the incidence of bone fractures and heart-related disorders, encouraging consumers to adopt preventive nutrition solutions. Healthcare professionals are also recommending vitamin K2 alongside vitamin D and calcium to support bone mineralization and cardiovascular health.
The increasing prevalence of cardiovascular risk factors is also encouraging consumers to seek nutritional ingredients that support vascular health and calcium regulation.
Limited Consumer Awareness in Developing Markets
Limited public awareness continues to restrain vitamin K2 market growth, particularly across developing economies where consumers are more familiar with vitamin D and calcium than vitamin K2. The absence of widespread nutrition education, lower healthcare awareness, and limited physician recommendations reduce product adoption despite increasing scientific evidence supporting vitamin K2 benefits.
In addition, premium pricing of vitamin K2 supplements and the limited availability of fortified food products in rural and price-sensitive regions continue to restrict broader market penetration. Manufacturers also face challenges in communicating the distinct health benefits of different vitamin K2 forms, including MK-4 and MK-7.
Growing scientific validation and strategic collaborations are creating new opportunities across vitamin K2 market trends. Ingredient manufacturers, supplement companies, and healthcare organizations are increasingly partnering to strengthen clinical evidence, expand professional education, and improve consumer awareness regarding the role of vitamin K2 in bone and cardiovascular health.
Increasing partnerships between ingredient suppliers and consumer health brands are also accelerating product innovation through fortified foods, dietary supplements, and functional nutrition products that address preventive healthcare needs.
Regulatory Variations and Limited Standardized Health Claims
One of the major challenges for the vitamin K2 industry is the variation in regulatory frameworks governing health claims, ingredient approvals, and labeling requirements across different countries. These differences make it difficult for manufacturers to maintain consistent marketing strategies and increase the time and cost required for product commercialization.
Request Customizationto receive a tailored report.
MK-7 Dominated the Market with 72.6% Share in 2025
MK-7 is the dominant product segment in the global vitamin K2 industry, accounting for 72.6% of the market in 2025. Its longer half-life and higher bioavailability compared to MK-4 enable better absorption and prolonged circulation in the body, making it particularly effective for supporting bone and cardiovascular health. Growing scientific evidence highlighting its role in calcium metabolism has increased consumer preference for MK-7, driving its widespread use in capsules, tablets, and fortified foods.
Capsules and Tablets Dominated the Market with 48.3% Share in 2025
Capsules and tablets dominate the vitamin K2 industry, accounting for 48.3% of the market in 2025, owing to their convenience, precise dosing, and long shelf life. These dosage forms are widely accepted among dietary supplement users and are easily distributed through pharmacies and health stores. They also enable manufacturers to combine Vitamin K2 with complementary nutrients such as Vitamin D and calcium, enhancing product effectiveness and reinforcing their leading market position.
Natural Vitamin K2 Dominated the Market with 64.7% Share in 2025
Natural Vitamin K2 is the dominant source segment, holding 64.7% of the market in 2025, driven by increasing consumer preference for naturally derived ingredients in dietary supplements and functional nutrition products. Naturally sourced Vitamin K2, particularly MK-7 obtained through fermentation, is widely recognized for its superior bioavailability and clean-label appeal. Growing demand for natural health products and preventive nutrition continues to strengthen the adoption of naturally sourced Vitamin K2 across global markets.
Bone Health Dominated the Market with 44.8% Share in 2025
Bone health leads the market, accounting for 44.8% of the global share in 2025, as Vitamin K2 plays a crucial role in calcium regulation and bone mineralization. With the rising prevalence of osteoporosis, particularly among postmenopausal women and the aging population, Vitamin K2 supplementation has become an important preventive solution. Clinical evidence supporting improved bone density and reduced fracture risk continues to drive demand for bone health-focused supplements.
Functional Foods and Beverages are Projected to Register the Fastest Growth at a CAGR of 12.1%
Health supplements lead the market with a 76.5% share in 2025, while functional foods and beverages are projected to register the fastest CAGR of 12.1% during the forecast period. Consumers increasingly prefer supplements as a convenient and reliable way to meet daily Vitamin K2 requirements for bone and cardiovascular health. Their availability through pharmacies and retail stores, along with formulations combining Vitamin D and calcium, continues to reinforce their market leadership.
Online Distribution is Projected to Register the Fastest Growth at a CAGR of 16.1%
Offline distribution dominates the market, accounting for 70.0% of total sales in 2025 through pharmacies, drug stores, hypermarkets, supermarkets, and other retail outlets. Consumers continue to prefer in-store purchases because of product authenticity, pharmacist guidance, and immediate availability. Although the online channel is expected to grow rapidly with a 16.1% CAGR, offline retail remains the primary sales channel due to its extensive distribution network and strong consumer trust.
Speak to an Analystto discuss market opportunities.
North America vitamin K2 market accounted for 37.2% of the global market, reaching USD 114.45 million in 2025, and is projected to grow at a CAGR of 12.1% during the forecast period. Growth is driven by rising consumer awareness of bone and cardiovascular health, increasing demand for dietary supplements, and expanding adoption of preventive healthcare. Growing availability of fortified foods and continuous product innovation further support regional market growth.
The US market was valued at USD 93.85 million in 2025, making it the largest contributor in North America. Rising demand for nutritional supplements, increasing prevalence of osteoporosis, expanding consumer focus on preventive wellness, and growing adoption of vitamin K2 in functional foods continue to strengthen market growth.
Canada's market reached USD 20.60 million in 2025. Growing awareness of bone health, increasing consumption of dietary supplements, rising demand for natural health products, and expanding retail availability of vitamin K2 formulations continue to support steady market expansion.
Europe vitamin K2 market accounted for 28.4% of the global market, reaching USD 87.38 million in 2025, and is expected to register a CAGR of 12.6% during the forecast period. Increasing aging populations, growing emphasis on preventive nutrition, rising demand for functional foods, and strong consumer awareness of cardiovascular and bone health continue to drive regional growth.
The UK market was valued at USD 15.73 million in 2025. Rising consumer interest in preventive healthcare, increasing use of vitamin supplements, expanding demand for fortified foods, and growing awareness of bone health continue to support market growth.
Germany's market accounted for USD 22.72 million in 2025. Strong demand for nutraceuticals, increasing adoption of preventive healthcare practices, expanding functional food consumption, and growing investment in nutritional innovation continue to support market expansion.
Asia Pacific vitamin K2 market accounted for 24.1% of the global market, valued at USD 74.15 million in 2025, and is projected to register a CAGR of 14.8% during the forecast period. Rising disposable incomes, increasing health consciousness, expanding dietary supplement consumption, and growing demand for fortified food products continue to accelerate regional market growth.
Japan's market generated USD 14.83 million in 2025. Long-standing consumption of vitamin K2-rich foods, increasing demand for healthy aging products, growing preference for preventive nutrition, and continuous innovation in functional foods continue to support market growth.
China's market accounted for USD 31.14 million in 2025, representing the largest share within Asia Pacific. Rising health awareness, expanding nutraceutical industry, increasing demand for dietary supplements, and growing investments in functional food manufacturing continue to drive market expansion.
Middle East & Africa vitamin K2 market accounted for 4.2% of the global market, totaling USD 12.92 million in 2025, and is anticipated to grow at a CAGR of 10.9% during the forecast period. Rising awareness of nutritional health, increasing healthcare expenditure, expanding dietary supplement availability, and growing demand for preventive wellness products continue to support regional expansion.
The UAE market was valued at USD 4.78 million in 2025. Growing consumer spending on health supplements, increasing awareness of bone and heart health, expanding premium nutrition retail channels, and rising demand for functional foods continue to drive market growth.
Africa's market reached USD 8.14 million in 2025. Improving healthcare access, increasing awareness of nutritional deficiencies, expanding distribution of dietary supplements, and growing demand for affordable preventive healthcare products continue to create long-term growth opportunities across the region.
Latin America vitamin K2 market accounted for 6.1% of the global market, reaching USD 18.77 million in 2025, and is projected to grow at a CAGR of 11.7% during the forecast period. Rising awareness of preventive nutrition, increasing dietary supplement consumption, expanding pharmacy distribution networks, and growing demand for functional foods continue to support regional market growth.
Brazil's market was valued at USD 9.01 million in 2025, making it the largest contributor in Latin America. Growing consumer awareness of bone and cardiovascular health, increasing demand for nutritional supplements, expanding retail availability of vitamin K2 products, and rising investment in the nutraceutical sector continue to strengthen market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Practice Lead
Anantika Sharma is a research practice lead with 7+ years of experience in the food & beverage and consumer products sectors. She specializes in analyzing market trends, consumer behavior, and product innovation strategies. Anantika's leadership in research ensures actionable insights that enable brands to thrive in competitive markets. Her expertise bridges data analytics with strategic foresight, empowering stakeholders to make informed, growth-oriented decisions.
We are featured on:
sales@straitsresearch.com